Works by Lee, Taehoon


Results: 95
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Histiocytic pleural effusion: the strong clue to malignancy.

    Published in:
    World Journal of Surgical Oncology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12957-021-02296-1
    By:
    • Chae, Ganghee;
    • Jun, Jae-Bum;
    • Jung, Hwa Sik;
    • Park, Chui Yong;
    • Kim, Jin Hyoung;
    • Kang, Byung Ju;
    • Kang, Hyeon Hui;
    • Ra, Seung Won;
    • Seo, Kwang Won;
    • Jegal, Yangjin;
    • Ahn, Jong Joon;
    • Park, Sang Hyuk;
    • Lee, Taehoon
    Publication type:
    Article
    26

    Multivariate analysis of prognostic factors in patients with pulmonary actinomycosis.

    Published in:
    BMC Infectious Diseases, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2334-14-10
    By:
    • Ji Young Park;
    • Taehoon Lee;
    • Hongyeul Lee;
    • Hyo-Jeong Lim;
    • Jinwoo Lee;
    • Jong Sun Park;
    • Young-Jae Cho;
    • Young Sik Park;
    • Chang-Hoon Lee;
    • Sang-Min Lee;
    • Ho Il Yoon;
    • Jae-Joon Yim;
    • Chul-Gyu Yoo;
    • Young Whan Kim;
    • Sung Koo Han;
    • Choon-Taek Lee;
    • Jae Ho Lee
    Publication type:
    Article
    27

    Multivariate analysis of prognostic factors in patients with pulmonary actinomycosis.

    Published in:
    BMC Infectious Diseases, 2014, v. 14, n. 1, p. 10, doi. 10.1186/1471-2334-14-10
    By:
    • Ji Young Park;
    • Taehoon Lee;
    • Hongyeul Lee;
    • Hyo-Jeong Lim;
    • Jinwoo Lee;
    • Jong Sun Park;
    • Young-Jae Cho;
    • Young Sik Park;
    • Chang-Hoon Lee;
    • Sang-Min Lee;
    • Ho Il Yoon;
    • Jae-Joon Yim;
    • Chul-Gyu Yoo;
    • Young Whan Kim;
    • Sung Koo Han;
    • Choon-Taek Lee;
    • Jae Ho Lee
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

    Published in:
    2019
    By:
    • Lee, Myungsun;
    • Mok, Jeongha;
    • Kim, Deog Kyeom;
    • Shim, Tae Sun;
    • Koh, Won-Jung;
    • Jeon, Doosoo;
    • Lee, Taehoon;
    • Lee, Seung Heon;
    • Kim, Ju Sang;
    • Park, Jae Seuk;
    • Lee, Ji Yeon;
    • Kim, Song Yee;
    • Lee, Jae Ho;
    • Jo, Kyung-Wook;
    • Jhun, Byung Woo;
    • Kang, Young Ae;
    • Ahn, Joong Hyun;
    • Kim, Chang-Ki;
    • Shin, Soyoun;
    • Song, Taeksun
    Publication type:
    journal article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50